Asthika Goonewardene
Stock Analyst at Truist Securities
(1.32)
# 3,589
Out of 4,984 analysts
90
Total ratings
37.93%
Success rate
-12.18%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Asthika Goonewardene
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JANX Janux Therapeutics | Initiates: Buy | $100 | $23.46 | +326.26% | 1 | Sep 10, 2025 | |
| RVMD Revolution Medicines | Initiates: Buy | $99 | $43.81 | +125.98% | 1 | Sep 5, 2025 | |
| MRSN Mersana Therapeutics | Maintains: Buy | $250 → $36 | $7.15 | +403.50% | 5 | Aug 14, 2025 | |
| GILD Gilead Sciences | Upgrades: Buy | $108 → $127 | $112.26 | +13.13% | 2 | Aug 8, 2025 | |
| EXEL Exelixis | Maintains: Buy | $56 → $49 | $40.44 | +21.17% | 11 | Jul 29, 2025 | |
| GMAB Genmab | Maintains: Buy | $45 → $46 | $28.08 | +63.82% | 15 | Jul 8, 2025 | |
| BNTX BioNTech SE | Reiterates: Buy | $151 → $155 | $98.15 | +57.92% | 3 | Jun 3, 2025 | |
| LEGN Legend Biotech | Maintains: Buy | $88 → $71 | $34.47 | +105.98% | 2 | May 14, 2025 | |
| ALLO Allogene Therapeutics | Maintains: Buy | $14 → $10 | $1.13 | +784.96% | 7 | May 14, 2025 | |
| AUTL Autolus Therapeutics | Maintains: Buy | $11 → $10 | $1.27 | +687.40% | 4 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $15 | $2.22 | +575.68% | 6 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $18.09 | +93.48% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $87 → $136 | $76.42 | +77.96% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $15 | $0.85 | +1,659.12% | 6 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $44 | $12.03 | +265.75% | 1 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $69 → $88 | $68.18 | +29.08% | 2 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $1.36 | +194.12% | 5 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 | $1.72 | +1,004.65% | 3 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $27 | $0.76 | +3,451.70% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Hold | $120 | $21.55 | +456.97% | 1 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $100 → $60 | $2.15 | +2,690.70% | 3 | Aug 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $228 → $180 | $5.55 | +3,143.24% | 4 | Aug 23, 2022 |
Janux Therapeutics
Sep 10, 2025
Initiates: Buy
Price Target: $100
Current: $23.46
Upside: +326.26%
Revolution Medicines
Sep 5, 2025
Initiates: Buy
Price Target: $99
Current: $43.81
Upside: +125.98%
Mersana Therapeutics
Aug 14, 2025
Maintains: Buy
Price Target: $250 → $36
Current: $7.15
Upside: +403.50%
Gilead Sciences
Aug 8, 2025
Upgrades: Buy
Price Target: $108 → $127
Current: $112.26
Upside: +13.13%
Exelixis
Jul 29, 2025
Maintains: Buy
Price Target: $56 → $49
Current: $40.44
Upside: +21.17%
Genmab
Jul 8, 2025
Maintains: Buy
Price Target: $45 → $46
Current: $28.08
Upside: +63.82%
BioNTech SE
Jun 3, 2025
Reiterates: Buy
Price Target: $151 → $155
Current: $98.15
Upside: +57.92%
Legend Biotech
May 14, 2025
Maintains: Buy
Price Target: $88 → $71
Current: $34.47
Upside: +105.98%
Allogene Therapeutics
May 14, 2025
Maintains: Buy
Price Target: $14 → $10
Current: $1.13
Upside: +784.96%
Autolus Therapeutics
Apr 1, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $1.27
Upside: +687.40%
Mar 3, 2025
Maintains: Buy
Price Target: $25 → $15
Current: $2.22
Upside: +575.68%
Jan 8, 2025
Initiates: Buy
Price Target: $35
Current: $18.09
Upside: +93.48%
Nov 12, 2024
Maintains: Buy
Price Target: $87 → $136
Current: $76.42
Upside: +77.96%
Aug 16, 2024
Maintains: Buy
Price Target: $18 → $15
Current: $0.85
Upside: +1,659.12%
Jun 24, 2024
Maintains: Buy
Price Target: $50 → $44
Current: $12.03
Upside: +265.75%
Jun 4, 2024
Maintains: Buy
Price Target: $69 → $88
Current: $68.18
Upside: +29.08%
May 21, 2024
Maintains: Buy
Price Target: $5 → $4
Current: $1.36
Upside: +194.12%
May 16, 2024
Maintains: Buy
Price Target: $19
Current: $1.72
Upside: +1,004.65%
Sep 6, 2023
Reiterates: Buy
Price Target: $27
Current: $0.76
Upside: +3,451.70%
Apr 5, 2023
Reinstates: Hold
Price Target: $120
Current: $21.55
Upside: +456.97%
Aug 23, 2022
Maintains: Hold
Price Target: $100 → $60
Current: $2.15
Upside: +2,690.70%
Aug 23, 2022
Maintains: Buy
Price Target: $228 → $180
Current: $5.55
Upside: +3,143.24%